Acerca de
news
Pentepebble
27/4/2022 | Healthtech fund focuses on GBA
Vigor Medical System
1/12/2021 | Selected as Hello Tomorrow Deep Tech Pioneer
Mixcare Health
29/4/2022 | 【疫症無情，但人間有愛】疫情下社會各界倍感壓力 數碼港「敢創抗疫」行動針對市民需要，提供支援
21/9/2021 | 【#本地初創推薦信】一站式IoT + AI健康監察與配對App 關注Wellness真 · 健康
Opharmic
28/4/2022 | Award-winning Opharmic technology and CeramTec ceramics enable non-invasive drug delivery
22/10/2021 | Opharmic wins grand prize at Asia Pacific Accelerator 2021 program
21/10/2021 | HK-based startup gets recognition for novel drug delivery device
20/10/2021 | MedTech Innovator Names Opharmic Technology as 2021 Asia Pacific Final Competition Winner
Thrive Bioscience
Jotbody
to be updated
CG Oncology
15/4/2022 | CG Oncology's Bladder Cancer Therapy Impresses at AACR
14/4/2022 | Oncolytic Adenovirus, CG0070, Plus Pembrolizumab Shows Promise in BCG-Unresponsive NMIBC
13/4/2022 | BCG不応の非筋層浸潤膀胱癌に腫瘍溶解ウイルスCG0070とペムブロリズマブの併用が有効である可能性
13/4/2022 | Pembrolizumab Plus CG0070 Induces Promising Response Rates in BCG-Unresponsive NMIBC
13/4/2022 | AACR22: After FerGene blowup, a startup touts even better bladder cancer gene therapy results in tiny study
20/12/2021 | CG Oncology Announces First Patient Dosed in Japan in Phase 3 Monotherapy Study of CG0070...
24/11/2021 | CG0070 Plus Pembrolizumab Yields Positive Preliminary Data in Non-Muscle Invasive Bladder Cancer
16/11/2021 | Pembrolizumab plus novel oncolytic immunotherapy shows early promise in NMIBC
13/11/2021 | CG Oncology Presents Preliminary Phase 2 Data with CG0070...
12/10/2021 | CG Oncology to Present Two Programs at The Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting